Nanoform

Nanoform is a publicly traded, service-oriented drug delivery company that provides nanoparticle engineering solutions to pharmaceutical and biotech partners. Its core proprietary technology, Controlled Expansion of Supercritical Solutions (CESS®), uses recycled supercritical CO2 to produce pure, excipient-free nanoparticles of both small and large molecules, addressing poor solubility and enabling high-drug-load formulations. The company's strategy is to act as a comprehensive development and manufacturing partner, helping clients improve drug performance from early development through commercialization, with a strong emphasis on sustainability and patient-centric design.

Controlled Expansion of Supercritical Solutions (CESS®): A green, solvent-free process using recycled supercritical CO2 to produce pure, excipient-free API nanoparticles as small as 10nm, enhancing solubility and enabling novel drug delivery formats.

Nanoform competes with CDMOs and tech firms offering alternative nanoparticle production methods (e.g., wet milling, spray drying). Its key differentiators are the excipient-free, solvent-free nature of its CESS® process, its strong sustainability profile, and its dual-platform capability addressing both small molecules and sensitive biologics.